DK1141019T3 - Fragment of the glycoprotein CD55 / DAF for the extraction of highly active tumor drugs and methods for its use - Google Patents

Fragment of the glycoprotein CD55 / DAF for the extraction of highly active tumor drugs and methods for its use

Info

Publication number
DK1141019T3
DK1141019T3 DK99969227T DK99969227T DK1141019T3 DK 1141019 T3 DK1141019 T3 DK 1141019T3 DK 99969227 T DK99969227 T DK 99969227T DK 99969227 T DK99969227 T DK 99969227T DK 1141019 T3 DK1141019 T3 DK 1141019T3
Authority
DK
Denmark
Prior art keywords
daf
glycoprotein
fragment
extraction
methods
Prior art date
Application number
DK99969227T
Other languages
Danish (da)
Inventor
Heinz Peter Vollmers
Hans Konrad Mueller-Hermelink
Original Assignee
Heinz Peter Vollmers
Hans Konrad Mueller-Hermelink
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19909771A external-priority patent/DE19909771A1/en
Application filed by Heinz Peter Vollmers, Hans Konrad Mueller-Hermelink filed Critical Heinz Peter Vollmers
Application granted granted Critical
Publication of DK1141019T3 publication Critical patent/DK1141019T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention relates to a substance and a method for producing anti-tumour agents. This substance corresponds to a fragment of the glycoprotein CD55/DAF and can also be used for diagnostic purposes.
DK99969227T 1998-12-22 1999-12-22 Fragment of the glycoprotein CD55 / DAF for the extraction of highly active tumor drugs and methods for its use DK1141019T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19859248 1998-12-22
DE19909771A DE19909771A1 (en) 1998-12-22 1999-03-05 Substance for the production of highly effective tumor drugs and methods
PCT/EP1999/010329 WO2000037489A2 (en) 1998-12-22 1999-12-22 Fragment of the gylcoprotein cd55/daf for producing highly effective anti-tumour medicaments and method for using the same

Publications (1)

Publication Number Publication Date
DK1141019T3 true DK1141019T3 (en) 2004-08-09

Family

ID=26050926

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99969227T DK1141019T3 (en) 1998-12-22 1999-12-22 Fragment of the glycoprotein CD55 / DAF for the extraction of highly active tumor drugs and methods for its use

Country Status (8)

Country Link
EP (1) EP1141019B1 (en)
AT (1) ATE264873T1 (en)
AU (2) AU772579B2 (en)
CA (1) CA2356189C (en)
DK (1) DK1141019T3 (en)
ES (1) ES2219108T3 (en)
PT (1) PT1141019E (en)
WO (1) WO2000037489A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011907A2 (en) 2001-07-24 2003-02-13 Mueller-Hermelink Hans Konrad Receptor, the use thereof, and mouse antibodies
WO2004005351A2 (en) 2002-07-04 2004-01-15 Oncomab Gmbh Neoplasm specific antibodies and uses thereof
GB0227644D0 (en) * 2002-11-27 2003-01-08 Cancer Rec Tech Ltd Specific binding members and uses thereof
DE10311248A1 (en) 2003-03-14 2004-09-30 Müller-Hermelink, Hans Konrad, Prof. Dr. Human monoclonal antibody
EP1531162A1 (en) 2003-11-14 2005-05-18 Heinz Vollmers Adenocarcinoma specific antibody SAM-6, and uses thereof
DE10353175A1 (en) 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Human monoclonal antibody with fatliquoring effect

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
GB9804065D0 (en) * 1998-02-26 1998-04-22 Cancer Res Campaign Tech Tumour associated antigen 791Tgp72

Also Published As

Publication number Publication date
AU772579B2 (en) 2004-04-29
CA2356189A1 (en) 2000-06-29
WO2000037489A3 (en) 2000-11-09
ATE264873T1 (en) 2004-05-15
AU2004203479A1 (en) 2004-08-26
EP1141019B1 (en) 2004-04-21
EP1141019A2 (en) 2001-10-10
WO2000037489A2 (en) 2000-06-29
ES2219108T3 (en) 2004-11-16
PT1141019E (en) 2004-09-30
CA2356189C (en) 2010-08-24
AU2795500A (en) 2000-07-12

Similar Documents

Publication Publication Date Title
ATE185971T1 (en) COMBINATION PREPARATION FOR THE TREATMENT OF HYPOGONADAL MEN AND MEN WITH HYPOPHYSIS DISEASES
ATE410446T1 (en) COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF Ovarian CANCER
DK1187632T3 (en) Treatment with anti-ErbB2 antibodies
DE69926348D1 (en) SYSTEM FOR THE ELECTROMAGNETIC IRRADIATION OF THE SKIN
DE69932125D1 (en) DEVICE FOR EXAMINING BODY FLUIDS
DK1434791T3 (en) Specific binding agents for human angiopoietin-2
NO20005864D0 (en) Quinasols for the treatment of brain tumor
DE69911125D1 (en) Device for administering anesthetics
DE60127977D1 (en) PROCESS FOR THE MANUFACTURE OF TEETH, HEAT-HARDENING OBJECTS AND THERMAL-HARDENING OBJECTS MADE THEREFOR
NO883306D0 (en) PHARMASOYYTIC ACTIVE CONJUGATES WITH IMPROVED BODY SPECIFIC BINDING SPECIFICITY.
DE60323875D1 (en) ATP RECYCLING LENGTH USING DEVICE FOR THE DISTINCTION OF ARRYTHMIES
DE60038478D1 (en) Device for the injection of contrast agents
CY1114614T1 (en) BLOOD FLU ANTIGENS ANTIGONS AND DISTRIBUTED DNA FRAGMENTS
DE69514857T2 (en) Device for the investigation of Helicobacter pylori infections
ATE297761T1 (en) PREPARATIONS FOR STABILIZING PEG-INTERFERON ALPHA CONJUGATES
DK1141019T3 (en) Fragment of the glycoprotein CD55 / DAF for the extraction of highly active tumor drugs and methods for its use
DE60037258D1 (en) SYSTEM FOR ADMINISTERING THE FINAL STOPPER
DE69737067D1 (en) VACCINE FOR THE TREATMENT OF MYCOSES
DE69916725D1 (en) DEVICE FOR PRODUCING CEMENT
DE19881185D2 (en) Device for the destruction or destruction of concretions
GT199900062A (en) EFFERVESCENT PREPARATIONS.
DE59904802D1 (en) Device for the treatment of biomolecules
ATE261724T1 (en) ANTICONVULSIVE DERIVATIVES FOR THE TREATMENT OF POST-TRAAUMATIC STRESS DISEASES
DE69804572T2 (en) Process for the preparation of bisphenol-A
DE69935156D1 (en) hCG THERAPY FOR THE TREATMENT OF METASTATIC BREAST CANCER